Nalaganje...

Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01)

INTRODUCTION: Pathologic complete response (pCR) after neoadjuvant chemotherapy has a demonstrated survival advantage; however, outcomes for non-pCR by receptor status are less understood. We sought to evaluate survival and distant recurrence by receptor status for patients with residual stage II/II...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Surg Oncol
Main Authors: Stankowski-Drengler, TJ, Schumacher, JR, Hanlon, B, Livingston-Rosanoff, D, Vande Walle, K, Greenberg, CC, Wilke, LG, Neuman, HB
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590230/
https://ncbi.nlm.nih.gov/pubmed/31900808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-07846-2
Oznake: Označite
Brez oznak, prvi označite!